Insulin aspart, recombinant Subcutaneous and Tranexamic Acid Injection
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Tranexamic Acid Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: tranexamic acid
Brand name: Cyklokapron, Lysteda
Synonyms: Tranexamic acid, Tranexamic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Tranexamic acid Intravenous
- Insulin aspart, recombinant Subcutaneous-Tranexamic Acid Tablet
- Insulin aspart, recombinant Subcutaneous-Tranexamic Acid Tablets
- Insulin aspart, recombinant Subcutaneous-Tranquil
- Insulin aspart, recombinant Subcutaneous-Transanosil
- Insulin aspart, recombinant Subcutaneous-Transderm-Nitro
- Tranexamic Acid Injection-Insulin degludec
- Tranexamic Acid Injection-Insulin Degludec (U-100) Prefilled Pens
- Tranexamic Acid Injection-Insulin Degludec (U-100) Vials
- Tranexamic Acid Injection-Insulin Degludec (U-200) Prefilled Pens
- Tranexamic Acid Injection-Insulin degludec and liraglutide
- Tranexamic Acid Injection-Insulin degludec and liraglutide Subcutaneous